Unmet medical needs among patients with gastroesophageal reflux disease: A foundation for improving management in primary care

Digestive Diseases

Volumn 27, Issue 1, 2009, Pages 62-67

  Liker, Harley R ^a   Ducrotté, Philippe ^b   Malfertheiner, Peter ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Burning Desires survey; Burning Questions survey; Over the counter medication; Quality of life

Indexed keywords

ANTACID AGENT;

ARTICLE; DISEASE SEVERITY; EATING; GASTROESOPHAGEAL REFLUX; HUMAN; PATIENT CARE; PATIENT COMPLIANCE; PERCEPTION; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP; WELLBEING;

COMMUNICATION; GASTROESOPHAGEAL REFLUX; HUMANS; NEEDS ASSESSMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; PRIMARY HEALTH CARE; QUALITY OF HEALTH CARE; QUALITY OF LIFE; SELF MEDICATION; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE;

EID: 65949122951     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210106     Document Type: Article

References (26)

1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R: The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101:1900-1920.
2. Malfertheiner P, Hallerback B: Clinical manifestations and complications of gastro-esophageal reflux disease (GERD). Int J Clin Pract 2005; 59:346-355.
3. Dent J, El-Serag HB, Wallander MA, Johansson S: Epidemiology of gastro-oesophageal ref lux disease: a systematic review. Gut 2005; 54:710-717.
4. Wiklund I, Carlsson J, Vakil N: Gastro-esophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am J Gastro-enterol 2006; 101:18-28.
5. Wiklund I: Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 2004; 22:108-114.
6. Shaker R: Nighttime GERD: clinical implications and therapeutic challenges. Best Pract Res Clin Gastroenterol 2004; 18 (suppl):31-38.
7. Liker H, Hungin P, Wiklund I: Managing gastroesophageal reflux disease in primary care: the patient perspective. J Am Board Fam Pract 2005; 18:393-400.
8. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, Lind T, Meyer-Sa-bellek W, Malfertheiner P, Stolte M, Willich SN: Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003; 18: 767-776.
9. Yi CH, Hu CT, Chen CL: Sleep dysfunction in patients with GERD: erosive versus non-erosive reflux disease. Am J Med Sci 2007; 334:168-170.
10. Johnsson F, Joelsson B, Gudmundsson K, Greif f L: Sy mptoms a nd endos c opic f indings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1987; 22:714-718.
11. Jones R: Gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol Suppl 1995; 211:35-38.
12. Smout AJ: The patient with GORD and chronically recurrent problems. Best Pract Res Clin Gastroenterol 2007; 21:365-378.
13. Fass R , Shapiro M, Dekel R , Sewell J: Systematicreview: proton-pump inhibitor failure in gastro-oesophageal reflux disease-where next? Aliment Pharmacol Ther 2005; 22:79-94.
14. Dekel R, Morse C, Fass R: The role of proton pump inhibitors in gastro-oesophageal re-f lu x disease. Drugs 2004; 64:277-295.
15. Tytgat GN: Review article: treatment of mild and severe cases of GERD. Aliment Pharmacol Ther 2002; 16(suppl 4):73-78.
16. Fass R: Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure. Drugs 2007; 67:1521-1530.
17. Thomson AB, Barkun AN, Armstrong D, Chiba N, White RJ, Daniels S, Escobedo S, Chakraborty B, Sinclair P, Van Zanten SJ: The prevalence of clinically significant en-doscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment-Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003; 17:1481-1491.
18. Crawley JA, Schmitt CM: How satisfied are chronic heartburn sufferers with their current medications? Results of the Patient Unmet Needs sur vey. JCOM 2000; 7:29-34.
19. McColl E, Junghard O, Wiklund I, Revicki DA: Assessing symptoms in gastroesopha-geal reflux disease: how well do clinicians' assessments agree with those of their patients? Am J Gastroenterol 2005; 100:11-18.
20. Jones R, Armstrong D, Malfertheiner P, Du-crotté P: Does the treatment of gastroesoph-ageal reflux disease (GERD) meet patients' needs? A survey-based study. Curr Med Res Opin 2006; 22:657-662.
21. Jones R, Liker HR, Ducrotté P: Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal ref lux disease. Int J Clin Pract 2007; 61:1301-1307.
22. Ducrotté P, Liker HR: How do people with gastro-oesophageal reflux disease perceive their disease? Results of a multinational survey. Curr Med Res Opin 2007; 23:2857-2865.
23. Jones R, Coyne K, Wiklund I: The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care. Aliment Pharmacol Ther 2007; 25:1451-1459.
24. Urnes J, Farup PG, Lydersen S, Petersen H: Patient education in gastro-oesophageal reflux disease: a randomized controlled trial. Eur J Gastroenterol Hepatol 2007; 19:1104-1110.
25. King A, MacDonald C, Örn C: Understanding gastro-oesophageal reflux disease: a patient-cluster analysis. Int J Clin Pract 2008; 62:1838-1843.
26. Dent J, Jones R, Vakil N, Halling K, Junghard O, Wernersson B, Lind T: A management strategy for GERD based on the Gastro-esophageal Reflux Disease Questionnaire (GerdQ) (abstract). Scand J Gastroenterol 2008; 43:34-35.